Literature DB >> 18752033

A population-based, case-control study of green tea consumption and leukemia risk in southwestern Taiwan.

Yau-Chang Kuo1, Chu-Ling Yu, Chen-Yu Liu, Su-Fen Wang, Pi-Chen Pan, Ming-Tsang Wu, Chi-Kung Ho, Yu-Shing Lo, Yi Li, David C Christiani.   

Abstract

OBJECTIVE: This study investigated the association between green tea consumption and leukemia.
METHODS: A total of 252 cases (90.3% response) and 637 controls (53.4% response) were enrolled. Controls were matched for cases on age and gender. Information was collected on participants' living habits, including tea consumption. Green tea was used as a standard to estimate the total amount of individual catechin consumption. We stratified individual consumption of catechins into four levels. Conditional logistic regression models were fit to subjects aged 0-15 and 16-29 years to evaluate separate associations between leukemia and catechin consumption.
RESULTS: A significant inverse association between green tea consumption and leukemia risk was found in individuals aged 16-29 years, whereas no significant association was found in the younger age groups. For the older group with higher amounts of tea consumption (>550 units of catechins), the adjusted odds ratio (OR) compared with the group without tea consumption was 0.47 [95% confidence interval (CI) = 0.23-0.97]. After we adjusted for smoking status and medical irradiation exposure, the overall OR for all participants was 0.49 (95% CI = 0.27-0.91), indicating an inverse relation between large amounts of catechins and leukemia.
CONCLUSION: Drinking sufficient amounts of tea, especially green tea, which contains more catechins than oolong tea and black tea, may reduce the risk of leukemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752033      PMCID: PMC3103781          DOI: 10.1007/s10552-008-9217-7

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  29 in total

1.  Green tea polyphenol epigallocatechin inhibits DNA replication and consequently induces leukemia cell apoptosis.

Authors:  D M Smith; Q P Dou
Journal:  Int J Mol Med       Date:  2001-06       Impact factor: 4.101

2.  Green tea: prevention and treatment of cancer by nutraceuticals.

Authors:  Richard Béliveau; Denis Gingras
Journal:  Lancet       Date:  2004 Sep 18-24       Impact factor: 79.321

Review 3.  Green tea in chemoprevention of cancer.

Authors:  H Mukhtar; N Ahmad
Journal:  Toxicol Sci       Date:  1999-12       Impact factor: 4.849

Review 4.  Diet and breast cancer: a review of the prospective observational studies.

Authors:  Karin B Michels; Anshu P Mohllajee; Edith Roset-Bahmanyar; Gregory P Beehler; Kirsten B Moysich
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860

5.  Relationship between antimutagenic activity and major components of various teas.

Authors:  G C Yen; H Y Chen
Journal:  Mutagenesis       Date:  1996-01       Impact factor: 3.000

Review 6.  Cancer chemoprevention by green tea components.

Authors:  H Mukhtar; S K Katiyar; R Agarwal
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

7.  Delineation of antimutagenic activity of catechin, epicatechin and green tea extract.

Authors:  Thiraviam Geetha; Amita Garg; Kanwaljit Chopra; Indu Pal Kaur
Journal:  Mutat Res       Date:  2004-11-22       Impact factor: 2.433

8.  Tea polyphenols as inhibitors of mutagenicity of major classes of carcinogens.

Authors:  J H Weisburger; Y Hara; L Dolan; F Q Luo; B Pittman; E Zang
Journal:  Mutat Res       Date:  1996-11-04       Impact factor: 2.433

9.  Anticarcinogenic activity of green tea polyphenols.

Authors:  A Komori; J Yatsunami; S Okabe; S Abe; K Hara; M Suganuma; S J Kim; H Fujiki
Journal:  Jpn J Clin Oncol       Date:  1993-06       Impact factor: 3.019

10.  Detection and chemical identification of natural bio-antimutagens. A case of the green tea factor.

Authors:  T Kada; K Kaneko; S Matsuzaki; T Matsuzaki; Y Hara
Journal:  Mutat Res       Date:  1985 Jun-Jul       Impact factor: 2.433

View more
  9 in total

Review 1.  Tea and cancer prevention: epidemiological studies.

Authors:  Jian-Min Yuan; Canlan Sun; Lesley M Butler
Journal:  Pharmacol Res       Date:  2011-03-23       Impact factor: 7.658

2.  Tea consumption and leukemia risk: a meta-analysis.

Authors:  Shanliang Zhong; Zhiyuan Chen; Xinnian Yu; Weixian Chen; Mengmeng Lv; Tengfei Ma; Jianhua Zhao
Journal:  Tumour Biol       Date:  2014-02-07

Review 3.  Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.

Authors:  Moshe Frenkel; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2017-10-14       Impact factor: 5.075

4.  Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia.

Authors:  Tait D Shanafelt; Timothy G Call; Clive S Zent; Jose F Leis; Betsy LaPlant; Deborah A Bowen; Michelle Roos; Kristina Laumann; Asish K Ghosh; Connie Lesnick; Mao-Jung Lee; Chung S Yang; Diane F Jelinek; Charles Erlichman; Neil E Kay
Journal:  Cancer       Date:  2012-07-03       Impact factor: 6.860

Review 5.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

6.  Green tea consumption and glutathione S-transferases genetic polymorphisms on the risk of adult leukemia.

Authors:  Ping Liu; Min Zhang; Xing Xie; Jie Jin; C D'Arcy J Holman
Journal:  Eur J Nutr       Date:  2015-11-17       Impact factor: 5.614

7.  Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells.

Authors:  Yuhui Huang; Motofumi Kumazoe; Jaehoon Bae; Shuhei Yamada; Mika Takai; Shiori Hidaka; Shuya Yamashita; Yoonhee Kim; Yeongseon Won; Motoki Murata; Shuntaro Tsukamoto; Hirofumi Tachibana
Journal:  Oncol Rep       Date:  2015-06-26       Impact factor: 3.906

8.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Tommaso Filippini; Marcella Malavolti; Francesca Borrelli; Angelo A Izzo; Susan J Fairweather-Tait; Markus Horneber; Marco Vinceti
Journal:  Cochrane Database Syst Rev       Date:  2020-03-02

9.  Effect of epicatechin against radiation-induced oral mucositis: in vitro and in vivo study.

Authors:  Yoo Seob Shin; Hyang Ae Shin; Sung Un Kang; Jang Hee Kim; Young-Taek Oh; Keun Hyung Park; Chul-Ho Kim
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.